ClinicalTrials.govpublic full text
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
carcinoma, transitional cell, urinary bladder neoplasms, urologic neoplasms, renal pelvis neoplasms, urothelial cancer, ureteral neoplasms, urethral neoplasms, asg-22me, asg-22ce, antibody-drug conjugate, antineoplastic agents, cpi
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 968895
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.